Enlivex Ltd. (ENLV) - Latest Market Data

Price & Market Data

Price: $0.73

Daily Change: +$0.0093 / 1.27%

Daily Range: $0.715 - $0.743

Market Cap: $172,952,448

Daily Volume: 111,979

Performance Metrics

1 Week: 2.33%

1 Month: -17.69%

3 Months: -28.42%

6 Months: -19.75%

1 Year: -25.87%

YTD: 1.19%

About Enlivex Ltd. (ENLV)

Comprehensive review of Enlivex Ltd. (ENLV). Trading at 0.73, the stock has seen a daily change of +$0.0093 / 1.27%. Its market capitalization is 172,952,448. All performance data is available for analysis.

Company Details

Employees: 34

Sector: Health technology

Industry: Biotechnology

Country: Israel

Details

Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.

Selected stocks

Annovis Bio, Inc. (ANVS)

ARB IOT Group Limited (ARBB)

Natuzzi, S.p.A. (NTZ)

Verde Clean Fuels, Inc. (VGAS)